Notification of Issue of Securities - NZ ESPS

01 March 2022
Capital Change Notice
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares under the Fisher & Paykel Healthcare New Zealand Employee Share Purchase Scheme (‘NZ Scheme’).

Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Ordinary shares
ISIN NZFAPE0001S2
Section 2: capital change details
Number issued 134,242
Nominal value (if any) Not applicable
Issue price NZD$20.43
Nature of the payment Cash payment
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued 0.02325%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue and specific authority for issue Issue of shares to the Trustees of the NZ Scheme to be held on trust under the NZ Scheme for those New Zealand employees accepting an offer to participate in the scheme (with a discount of up to $500 per employee), in accordance with the terms of the scheme as set out in the Trust Deed dated 26 September 2019.
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. Total number (excluding Treasury Stock): 577,265,047 shares
Treasury stock as at the date of this notice: 137,282.
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (including Treasury Stock): 577,402,329.
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution dated 04 November 2021
Terms or details of the issue The shares rank pari passu with the existing ordinary shares
Date of issue 28 February 2022
Section 3: authority for this announcement
Name of person authorised to make this announcement Raelene Leonard
Contact phone number +64 9 574 0147
Contact email address [email protected]
Date of release via MAP 01 March 2022

---

Announcement PDF